Elevated Serum MicroRNA Let-7c in Moyamoya Disease
Elevated Serum MicroRNA Let-7c in Moyamoya Disease
复制标题
烟雾病血清 MicroRNA Let-7c 升高
DOI:
10.1016/j.jstrokecerebrovasdis.2015.01.041
复制
发表时间:
2015
影响因子:
2.5
通讯作者:
Jia Yanjie
中科院分区:
文献类型:
--
作者:
Zhao Shaoyun;Gong Zhe;Zhang Jing;Xu Xiaoge;Liu Peidong;Guan Wenjuan;Jing Lijun;Peng Tao;Teng Junfang;Jia Yanjie
BackgroundFew studies have examined the relationship between mircroRNAs and moyamoya disease (MMD). We performed a study of the significance of let-7c expression in the serum of MMD patients.MethodsThe experimental group includes 49 MMD patients, and the control group consists of 30 normal people, 20 cerebral hemorrhage patients, 20 massive cerebral infarction patients, 20 nonmassive cerebral infarction patients, and 20 neurological autoimmune disease patients. Let-7 family levels were determined by polymerase chain reaction. A dual luciferase assay was used to test whether let-7c recognized the 3′UTR ofRNF213.ResultsThe expression level of let-7c in MMD patients is higher than that observed in the control groups (P< .001). The luciferase assay results indicated that hsa-let-7c could diminish luciferase activity from a reporter vector containing the 3′-UTR ofRNF213(P< .05). The suppression of luciferase activity is not found in mutRNF213(P> .05).ConclusionsIncreased expression of let-7c in MMD patients may contribute to MMD pathogenesis by targetingRNF213. Thus, let-7c may be a potential biomarker for the diagnosis of MMD.